Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

John W. Eikelboom; Deepak L. Bhatt; Keith A.A. Fox; Jackie Bosch; Stuart J. Connolly; Sonia S. Anand; Álvaro Avezum; Scott D. Berkowitz; Kelley R. Branch; Gilles R. Dagenais; Camilo Félix; Tomasz J. Guzik; Robert G. Hart; Aldo Maggioni; Eva Muehlhofer; Mukul Sharma; Olga Shestakovska; Salim Yusuf

doi:10.1016/j.jacc.2021.04.083

Related publications

Article2019

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Olga Shestakovska, Gilles R. Dagenais, Robert G. Hart, Darryl P. Leong, Martin O’Donnell, Keith A.A. Fox, Deepak L. Bhatt, John A. Cairns, Christoph Tasto, Scott D. Berkowitz, Nancy Cook Bruns, Eva Muehlhofer, Rafael Díaz, Aldo Maggioni, Salim Yusuf

Article2019

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

Kelley R. Branch, Jeffrey L. Probstfield, John W. Eikelboom, Jackie Bosch, Aldo Maggioni, Richard K. Cheng, Deepak L. Bhatt, Álvaro Avezum, Keith A.A. Fox, Stuart J. Connolly, Olga Shestakovska, Salim Yusuf

Article2023

Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

Petr Widimský, Stuart J. Connolly, Quilong Yi, Olga Shestakovska, Salim Yusuf, John W. Eikelboom, Kelley R. Branch, Jeffrey L. Probstfield, Jackie Bosch, Deepak L. Bhatt, Aldo Maggioni, Eva Muehlhofer, Álvaro Avezum

Article2022

Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial

Masatsugu Hori, Jun Zhu, Yan Liang, Deepak L. Bhatt, Jackie Bosch, Stuart J. Connolly, Keith A.A. Fox, Aldo Maggioni, Salim Yusuf, John W. Eikelboom

Article2021

Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy

Pietro Ferrara, Paolo Angelo Cortesi, Danilo Di Laura, Aldo Maggioni, LG Mantovani